NBRV - Nabriva Therapeutics EPS in-line beats on revenue November, 05 2020 04:05 PM Nabriva Therapeutics plc Nabriva Therapeutics (NBRV): Q3 GAAP EPS of -$0.09 in-line.Revenue of $1.29M (-81.4% Y/Y) beats by $0.84M.Shares +0.37%.Press Release For further details see: Nabriva Therapeutics EPS in-line, beats on revenue